On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Santaris Pharma A/S's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.5M · 3 projects
Projects
3 EU-funded projects, newest first. Each links to the official record.
- Athero-B-CellPartner
Targeting and exploiting B cell functions for treatment in cardiovascular disease
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€1.0Mtheir share - Athero-FluxPartner
Targeting novel lipid pathways for treatment of cardiovascular disease
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€517ktheir share - CARDIOMIRPartner
Development of microRNA Medicines for Cardiac Metabolic Diseases; A Targeted European Exchange Programme
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Karolinska InstitutetSweden · 2 shared projects
- Alta Ricerca e Sviluppo In Biotecnologie SrluItaly · 2 shared projects
- Cenix Bioscience GmbHGermany · 2 shared projects
- Weizmann Institute of ScienceIsrael · 1 shared project
- Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
- Universiteit MaastrichtNetherlands · 1 shared project
- Universite de GeneveSwitzerland · 1 shared project
- University College LondonUnited Kingdom · 1 shared project
- Institut PasteurFrance · 1 shared project
- Universite de LiegeBelgium · 1 shared project
- Syddansk UniversitetDenmark · 1 shared project
- Universita Degli Studi di GenovaItaly · 1 shared project
- MAX IV Laboratory, Lund UniversitySweden · 1 shared project
- Idryma Iatroviologikon Ereunon Akademias AthinonGreece · 1 shared project
- Zora Biosciences OyFinland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- arteriosclerosis
- cardiovascular diseases
- data science
- drug discovery
- genetic engineering
- inflammatory diseases
- lipids
- mortality
- nucleotides
- proteins
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
